FY25 earnings show solid revenue growth, but flat Armv9 adoption. Read more to see why I'm bearish on ARM stock.

NewAmsterdam Pharma's obicetrapib lowers LDL-C in Phase 3 trials, showing promise as a CETP inhibitor. Read more on NAMS ...

The Spurs phenom suffered a season-ending injury. A physician explains what deep vein thrombosis is, its causes and treatment ...

This $330 smartwatch can outlast its competitors in battery life and fitness features, but may fall short on software updates ...

Investment in robotics may be substantial, but long-term benefits of automation include lower labour costs and more ...

The Dell UtraSharp 32 4K Thunderbolt Hub Monitor is a solid value. It offers a crisp, vivid IPS Black 4K display for under $1 ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Keeping up with everything going on around baseball is tough enough in the best of times, but it's more true during Spring ...

Nunez has an unusually short stride for a hard thrower, falls to the first base side while spinning off his landing heel and ...

If you want a CPU that has the floating point performance of a GPU, all you have to do is wait six or so years and the CPU ...

HMRC, the Labour Party government's tax arm, pocketed more than £409m in interest charges alone last year, figures have shown ...

A group of experts consider the accessories from the past 100 years that changed how we carry our things — and ourselves.